BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21940482)

  • 1. Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease.
    Breit SN; Carrero JJ; Tsai VW; Yagoutifam N; Luo W; Kuffner T; Bauskin AR; Wu L; Jiang L; Barany P; Heimburger O; Murikami MA; Apple FS; Marquis CP; Macia L; Lin S; Sainsbury A; Herzog H; Law M; Stenvinkel P; Brown DA
    Nephrol Dial Transplant; 2012 Jan; 27(1):70-5. PubMed ID: 21940482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.
    Liabeuf S; Barreto DV; Barreto FC; Chasseraud M; Brazier M; Choukroun G; Kamel S; Massy ZA
    Nephrol Dial Transplant; 2010 Aug; 25(8):2596-602. PubMed ID: 20190248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality.
    Wiklund FE; Bennet AM; Magnusson PK; Eriksson UK; Lindmark F; Wu L; Yaghoutyfam N; Marquis CP; Stattin P; Pedersen NL; Adami HO; Grönberg H; Breit SN; Brown DA
    Aging Cell; 2010 Dec; 9(6):1057-64. PubMed ID: 20854422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TGF-β superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism.
    Breit SN; Johnen H; Cook AD; Tsai VW; Mohammad MG; Kuffner T; Zhang HP; Marquis CP; Jiang L; Lockwood G; Lee-Ng M; Husaini Y; Wu L; Hamilton JA; Brown DA
    Growth Factors; 2011 Oct; 29(5):187-95. PubMed ID: 21831009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.
    Carrero JJ; Chmielewski M; Axelsson J; Snaedal S; Heimbürger O; Bárány P; Suliman ME; Lindholm B; Stenvinkel P; Qureshi AR
    Clin Nutr; 2008 Aug; 27(4):557-64. PubMed ID: 18538898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients.
    Yuan J; Guo Q; Qureshi AR; Anderstam B; Eriksson M; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2013 Sep; 28(9):2356-63. PubMed ID: 23828162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual variation in body fat is associated with systemic inflammation in chronic kidney disease patients Stages 3 and 4: a longitudinal study.
    Carvalho LK; Barreto Silva MI; da Silva Vale B; Bregman R; Martucci RB; Carrero JJ; Avesani CM
    Nephrol Dial Transplant; 2012 Apr; 27(4):1423-8. PubMed ID: 21825305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
    Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
    Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
    Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
    Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
    J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis.
    Kovesdy CP; Anderson JE; Kalantar-Zadeh K
    Am J Kidney Dis; 2007 May; 49(5):581-91. PubMed ID: 17472839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.
    Qureshi AR; Alvestrand A; Divino-Filho JC; Gutierrez A; Heimbürger O; Lindholm B; Bergström J
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S28-36. PubMed ID: 11792759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study.
    Panichi V; Rosati A; Bigazzi R; Paoletti S; Mantuano E; Beati S; Marchetti V; Bernabini G; Grazi G; Rizza GM; Migliori M; Giusti R; Lippi A; Casani A; Barsotti G; Tetta C;
    Nephrol Dial Transplant; 2011 Aug; 26(8):2641-8. PubMed ID: 21325348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum mannose-binding lectin levels in maintenance hemodialysis patients: impact on all-cause mortality.
    Satomura A; Endo M; Fujita T; Ohi H; Ohsawa I; Fuke Y; Matsumoto K; Sudo S; Matsushita M; Fujita T
    Nephron Clin Pract; 2006; 102(3-4):c93-9. PubMed ID: 16282701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and malnutrition as predictors of mortality in patients on hemodialysis.
    Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Díez JJ; Vázquez A
    J Nephrol; 2002; 15(2):136-43. PubMed ID: 12018629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent and joint associations of nutritional status indicators with mortality risk among chronic hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Lopes AA; Bragg-Gresham JL; Elder SJ; Ginsberg N; Goodkin DA; Pifer T; Lameire N; Marshall MR; Asano Y; Akizawa T; Pisoni RL; Young EW; Port FK
    J Ren Nutr; 2010 Jul; 20(4):224-34. PubMed ID: 20060319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes.
    Yilmaz MI; Stenvinkel P; Sonmez A; Saglam M; Yaman H; Kilic S; Eyileten T; Caglar K; Oguz Y; Vural A; Çakar M; Altun B; Yenicesu M; Carrero JJ
    Nephrol Dial Transplant; 2011 Nov; 26(11):3537-43. PubMed ID: 21378154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.